Participated in Coultreon Biopharma's $125M Series A for its immunology pipeline.
Coultreon Biopharma is focused on developing life-changing medicines for patients affected by chronic inflammatory diseases, leveraging expertise in immunology and drug discovery to create innovative oral therapies
Coultreon Biopharma is focused on developing life-changing medicines for patients affected by chronic inflammatory diseases, leveraging expertise in immunology and drug discovery to create innovative oral therapies.